Qwo

Product NDC: 73611-300
Requested package NDC: 73611-300-10
11-digit product format: 736110300
Labeler code: 73611
Product ID: 73611-300_27123a3f-bca4-4049-b32f-d88b8327ac88
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: collagenase clostridium histolyticum-aaes
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRALESIONAL
Labeler: Endo Aesthetics LLC
Application: BLA761146
Marketing category: BLA
Marketing start: 2021-02-01
Marketing end: 0000-00-00
Substance: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Active strength: 0 mg/mL
Pharmacologic classes: Collagen-specific Enzyme [EPC], Collagenases [Chemical/Ingredient]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	73611-300	73611-300-10	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761146	Qwo	collagenase clostridium histolyticum-aaes	351(a)	Disc	2026-07-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9X7O8V25IT	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	9001-12-1	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
73611-300-10	73611030010	1 VIAL in 1 CARTON (73611-300-10) > 8 mL in 1 VIAL	1 vial	2021-02-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Qwo	Endo Aesthetics LLC \| Auxilium Pharmaceuticals, LLC \| Par Sterile Products LLC \| Sharp Corporation	2022-07-22	HUMAN PRESCRIPTION DRUG LABEL	8

Qwo

NDC auxiliary status#

Observed NDC auxiliary status history#

Related Records#

Purple Book Biologic Products#

Related UNII Ingredients#

Packages#

Related DailyMed Labels#